These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27559425)

  • 1. Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.
    Meijer FJ; Steens SC; van Rumund A; van Cappellen van Walsum AM; Küsters B; Esselink RA; Verbeek MM; Bloem BR; Goraj B
    Pol J Radiol; 2016; 81():363-9. PubMed ID: 27559425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
    Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP
    PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism.
    Kathuria H; Mehta S; Ahuja CK; Chakravarty K; Ray S; Mittal BR; Singh P; Lal V
    Mov Disord Clin Pract; 2021 Feb; 8(2):224-230. PubMed ID: 33553492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnostic performance of susceptibility-weighted imaging with compressed sensing-sensitivity encoding and neuromelanin-sensitive MRI for Parkinson's disease and atypical Parkinsonism.
    Lee DH; Heo H; Suh CH; Shim WH; Kim E; Jo S; Chung SJ; Lee CS; Kim HS; Kim SJ
    Clin Radiol; 2024 Jan; 79(1):e102-e111. PubMed ID: 37863747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Nigrosome-1 Sign Identification via Interpretable AI using True Susceptibility Weighted Imaging.
    Wang C; He N; Zhang Y; Li Y; Huang P; Liu Y; Jin Z; Cheng Z; Liu Y; Wang Y; Zhang C; Haacke EM; Chen S; Yan F; Yang G
    J Magn Reson Imaging; 2024 Nov; 60(5):1904-1915. PubMed ID: 38236577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.
    Pavese N; Tai YF
    Mov Disord Clin Pract; 2018; 5(2):131-140. PubMed ID: 30363419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism.
    Biswas D; Banerjee R; Sarkar S; Choudhury S; Sanyal P; Tiwari M; Kumar H
    Ann Indian Acad Neurol; 2022; 25(6):1029-1035. PubMed ID: 36911494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    Lee J; Lee AL; Park JH; Moon JE; Park JM; Kim SJ; Chang KH
    PLoS One; 2020; 15(4):e0231010. PubMed ID: 32240236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Swallow Tail Sign of Substantia Nigra: A Case-Control Study to Establish Its Role in Diagnosis of Parkinson Disease on 3T MRI.
    Gupta R; Kumar G; Kumar S; Thakur B; Tiwari R; Verma AK
    J Neurosci Rural Pract; 2022 Apr; 13(2):181-185. PubMed ID: 35694067
    [No Abstract]   [Full Text] [Related]  

  • 12. Substantia nigra nigrosome-1 imaging correlates with the severity of motor symptoms in Parkinson's disease.
    Chu YT; Yu CF; Fan SP; Chen TF; Chiu MJ; Jang JR; Chiu SI; Lin CH
    J Neurol Sci; 2023 Aug; 451():120731. PubMed ID: 37454574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvessels may Confound the "Swallow Tail Sign" in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study.
    Kau T; Hametner S; Endmayr V; Deistung A; Prihoda M; Haimburger E; Menard C; Haider T; Höftberger R; Robinson S; Reichenbach JR; Lassmann H; Traxler H; Trattnig S; Grabner G
    J Neuroimaging; 2019 Jan; 29(1):65-69. PubMed ID: 30407679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
    De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
    Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign.
    Schmidt MA; Engelhorn T; Marxreiter F; Winkler J; Lang S; Kloska S; Goelitz P; Doerfler A
    BMC Neurol; 2017 Oct; 17(1):194. PubMed ID: 29073886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.
    Mahlknecht P; Krismer F; Poewe W; Seppi K
    Mov Disord; 2017 Apr; 32(4):619-623. PubMed ID: 28151553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: A systematic review and meta-analysis.
    Chau MT; Todd G; Wilcox R; Agzarian M; Bezak E
    Parkinsonism Relat Disord; 2020 Sep; 78():12-20. PubMed ID: 32668370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical MR imaging in Parkinson's disease: How useful is the swallow tail sign?
    Prasuhn J; Neumann A; Strautz R; Dreischmeier S; Lemmer F; Hanssen H; Heldmann M; Schramm P; Brüggemann N
    Brain Behav; 2021 Jul; 11(7):e02202. PubMed ID: 34032020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 6-[
    Michler E; Kaiser D; Eleftheriadou K; Falkenburger B; Kotzerke J; Hoberück S
    EJNMMI Res; 2021 Feb; 11(1):16. PubMed ID: 33590381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.